Synopsis Cancer cells are glycolytic in nature and this offers for a potential treatment target which can be addressed by Ketogenic Diet (KD). The present study aimed to verify the hypothesis that a KD can improve body composition and reduce serum insulin and insulin-like growth factor-I (IGF-I) in women with ovarian or endometrial cancer . This week’s “ MED FACT ” discusses a clinical trial from The Journal of Nutrition, “ A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer .” Authors: Cohen et al.
Key Takeaways A KD results in loss of fat mass and retention of lean mass in women with ovarian or endometrial cancer. Visceral fat and fasting serum insulin also reduced by a KD. Objective: The study aimed to verify the hypothesis that a KD can improve body composition and reduce serum insulin and insulin-like growth factor-I (IGF-I) in…
